Bachmann's Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy.

IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiology Research and Practice Pub Date : 2023-10-27 eCollection Date: 2023-01-01 DOI:10.1155/2023/2870188
Jiaqi Sun, Sanbao Chen, Ming Liang, Qi Zhang, Ping Zhang, Mingyu Sun, Jian Ding, Zhiqing Jin, Yaling Han, Zulu Wang
{"title":"Bachmann's Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy.","authors":"Jiaqi Sun,&nbsp;Sanbao Chen,&nbsp;Ming Liang,&nbsp;Qi Zhang,&nbsp;Ping Zhang,&nbsp;Mingyu Sun,&nbsp;Jian Ding,&nbsp;Zhiqing Jin,&nbsp;Yaling Han,&nbsp;Zulu Wang","doi":"10.1155/2023/2870188","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bachmann's bundle (BB) is the main pathway of interatrial connection that could be involved in the development of atrial fibrillation (AF). Based on this hypothesis, we raised a novel ablation strategy, BB modification in addition to circumferential pulmonary vein isolation (CPVI-BB) in patients with AF.</p><p><strong>Methods: </strong>A retrospective cohort of patients with AF who underwent CPVI-BB or CPVI alone from March 2018 to July 2021 was enrolled in our study. Propensity score matching was performed in patients with paroxysmal AF and persistent AF, respectively, to reduce the risk of selection bias between the treatment strategies (CPVI-BB or CPVI alone). The primary endpoint was overall freedom from atrial arrhythmia recurrence through 12 months of follow-up.</p><p><strong>Results: </strong>Our propensity score-matched cohort included 82 patients with paroxysmal AF (CPVI group: <i>n</i> = 41; CPVI-BB group: <i>n</i> = 41) and 168 patients with persistent AF (CPVI group: <i>n</i> = 84; CPVI-BB group: <i>n</i> = 84). Among patients with persistent AF, one-year freedom from atrial arrhythmia recurrence rate was 83.3% in the CPVI-BB group and 70.2% in the CPVI group (log-rank <i>P</i> = 0.047). Among patients with paroxysmal AF, no significant difference was found in the primary endpoint between two groups (85.4% in the CPVI-BB group vs. 80.5% in the CPVI group; log-rank <i>P</i> = 0.581). In addition, procedure-related complications and recurrence of atrial tachycardia or atrial flutter were similar between the two treatment groups, regardless of the type of AF.</p><p><strong>Conclusions: </strong>BB modification in addition to CPVI is an effective approach in increasing the maintenance of sinus rhythm in patients with persistent AF, while it does not improve the clinical outcomes of radiofrequency catheter ablation in patients with paroxysmal AF.</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"2870188"},"PeriodicalIF":1.8000,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624549/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology Research and Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/2870188","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Bachmann's bundle (BB) is the main pathway of interatrial connection that could be involved in the development of atrial fibrillation (AF). Based on this hypothesis, we raised a novel ablation strategy, BB modification in addition to circumferential pulmonary vein isolation (CPVI-BB) in patients with AF.

Methods: A retrospective cohort of patients with AF who underwent CPVI-BB or CPVI alone from March 2018 to July 2021 was enrolled in our study. Propensity score matching was performed in patients with paroxysmal AF and persistent AF, respectively, to reduce the risk of selection bias between the treatment strategies (CPVI-BB or CPVI alone). The primary endpoint was overall freedom from atrial arrhythmia recurrence through 12 months of follow-up.

Results: Our propensity score-matched cohort included 82 patients with paroxysmal AF (CPVI group: n = 41; CPVI-BB group: n = 41) and 168 patients with persistent AF (CPVI group: n = 84; CPVI-BB group: n = 84). Among patients with persistent AF, one-year freedom from atrial arrhythmia recurrence rate was 83.3% in the CPVI-BB group and 70.2% in the CPVI group (log-rank P = 0.047). Among patients with paroxysmal AF, no significant difference was found in the primary endpoint between two groups (85.4% in the CPVI-BB group vs. 80.5% in the CPVI group; log-rank P = 0.581). In addition, procedure-related complications and recurrence of atrial tachycardia or atrial flutter were similar between the two treatment groups, regardless of the type of AF.

Conclusions: BB modification in addition to CPVI is an effective approach in increasing the maintenance of sinus rhythm in patients with persistent AF, while it does not improve the clinical outcomes of radiofrequency catheter ablation in patients with paroxysmal AF.

Abstract Image

Abstract Image

Abstract Image

Bachmann氏束改良加环肺静脉隔离治疗心房颤动:一种新的消融策略。
背景:巴赫曼束(BB)是心房颤动(AF)发生发展过程中心房连接的主要途径。基于这一假设,我们在房颤患者中提出了一种新的消融策略,即除环肺静脉隔离(CPVI-BB)外的BB改良。方法:我们的研究纳入了2018年3月至2021年7月单独接受CPVI-BC或CPVI的房颤患者的回顾性队列。分别对阵发性房颤和持续性房颤患者进行倾向性评分匹配,以降低治疗策略(CPVI-BB或单独CPVI)之间选择偏差的风险。主要终点是12个月内完全无房性心律失常复发 结果:我们的倾向评分匹配队列包括82例阵发性房颤患者(CPVI组:n = 41;CPVI-BB组:n = 41)和168例持续性房颤患者(CPVI组:n = 84;CPVI-BB组:n = 84)。在持续性房颤患者中,CPVI-BB组一年无心律失常复发率为83.3%,CPVI组为70.2%(log秩P = 0.047)。在阵发性房颤患者中,两组之间的主要终点没有发现显著差异(CPVI-BB组为85.4%,CPVI组为80.5%;log秩P = 0.581)。此外,无论房颤类型如何,两个治疗组的手术相关并发症和房性心动过速或房扑复发情况相似。结论:在CPVI的基础上改良BB是增加持续性房颤患者窦性心律维持的有效方法,而它不能改善阵发性房颤患者的射频导管消融的临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiology Research and Practice
Cardiology Research and Practice Medicine-Cardiology and Cardiovascular Medicine
CiteScore
4.40
自引率
0.00%
发文量
64
审稿时长
13 weeks
期刊介绍: Cardiology Research and Practice is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies that focus on the diagnosis and treatment of cardiovascular disease. The journal welcomes submissions related to systemic hypertension, arrhythmia, congestive heart failure, valvular heart disease, vascular disease, congenital heart disease, and cardiomyopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信